Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection

大量预先存在的T细胞克隆驱动针对SARS-CoV-2和LCMV感染的早期免疫。

阅读:7
作者:Martina Milighetti ,Yanchun Peng ,Cedric Tan ,Michal Mark ,Gayathri Nageswaran ,Suzanne Byrne ,Tahel Ronel ,Tom Peacock ,Andreas Mayer ,Aneesh Chandran ,Joshua Rosenheim ,Matthew Whelan ,Xuan Yao ,Guihai Liu ,Suet Ling Felce ,Tao Dong ,Alexander J Mentzer ,Julian C Knight ,Francois Balloux ,Erez Greenstein ,Shlomit Reich-Zeliger ,Corinna Pade ,Joseph M Gibbons ,Amanda Semper ,Tim Brooks ,Ashley Otter ,Daniel M Altmann ,Rosemary J Boyton ,Mala K Maini ,Aine McKnight ,Charlotte Manisty ,Thomas A Treibel ,James C Moon ,Benny Chain

Abstract

T cell responses precede antibody and may provide early control of infection. We analyzed the clonal basis of this rapid response following SARS-COV-2 infection. We applied T cell receptor (TCR) sequencing to define the trajectories of individual T cell clones immediately. In SARS-COV-2 PCR+ individuals, a wave of TCRs strongly but transiently expand, frequently peaking the same week as the first positive PCR test. These expanding TCR CDR3s were enriched for sequences functionally annotated as SARS-COV-2 specific. Epitopes recognized by the expanding TCRs were highly conserved between SARS-COV-2 strains but not with circulating human coronaviruses. Many expanding CDR3s were present at high frequency in pre-pandemic repertoires. Early response TCRs specific for lymphocytic choriomeningitis virus epitopes were also found at high frequency in the preinfection naive repertoire. High-frequency naive precursors may allow the T cell response to respond rapidly during the crucial early phases of acute viral infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。